These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33962837)

  • 1. Nigeria experience on the use of polio assets for the 2017/18 measles vaccination campaign follow-up.
    Oteri AJ; Adamu U; Dieng B; Bawa S; Terna N; Nsubuga P; Owoaje ET; Kassogue M; Jean Baptiste AE; Braka F; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C3-C11. PubMed ID: 33962837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polio Legacy in Action: Using the Polio Eradication Infrastructure for Measles Elimination in Nigeria-The National Stop Transmission of Polio Program.
    Michael CA; Waziri N; Gunnala R; Biya O; Kretsinger K; Wiesen E; Goodson JL; Esapa L; Gidado S; Uba B; Nguku P; Cochi S
    J Infect Dis; 2017 Jul; 216(suppl_1):S373-S379. PubMed ID: 28838182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensified Local Resource Mobilization for the Polio Eradication Initiative: The Experience of World Health Organization in Nigeria During 2008-2015.
    Yehualashet YG; Horton J; Mkanda P; Vaz RG; Afolabi O; Gashu SG; Banda R; O'Malley H; Nsubuga P
    J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S101-7. PubMed ID: 26912380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategic Engagement of Technical Surge Capacity for Intensified Polio Eradication Initiative in Nigeria, 2012-2015.
    Yehualashet YG; Mkanda P; Gasasira A; Erbeto T; Onimisi A; Horton J; Banda R; Tegegn SG; Ahmed H; Afolabi O; Wadda A; Vaz RG; Nsubuga P
    J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S116-23. PubMed ID: 26912379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transitioning Lessons Learned and Assets of the Global Polio Eradication Initiative to Global and Regional Measles and Rubella Elimination.
    Kretsinger K; Strebel P; Kezaala R; Goodson JL
    J Infect Dis; 2017 Jul; 216(suppl_1):S308-S315. PubMed ID: 28838195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Providing information for decision-making in the Nigerian Polio Eradication Program, 2016-2020.
    Erbeto T; Bammeke P; Aregay A; Kamran Z; Ibrahim A; Usifoh N; Adamu U; Omotayo B; Braka F; Damisa E; Kazadi W; Shuaib F
    Pan Afr Med J; 2023; 45(Suppl 2):11. PubMed ID: 38370106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse events following immunization: Findings from 2017/2018 measles vaccination campaign, Nigeria AEFI reporting in 2017/2018 measles vaccination campaign.
    Gbenewei E; Nomhwange T; Taiwo L; Ayodeji I; Yusuf K; Jean Baptiste AE; Nsubuga P; Braka F; Oteri J; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C82-C88. PubMed ID: 33714655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of the Geographic Information System (GIS) in immunisation service delivery; its use in the 2017/2018 measles vaccination campaign in Nigeria.
    Oteri J; Idi Hussaini M; Bawa S; Ibizugbe S; Lambo K; Mogekwu F; Wiwa O; Seaman V; Kolbe-Booysen O; Braka F; Nsubuga P; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C29-C37. PubMed ID: 33478790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress toward poliomyelitis eradication - Nigeria, January 2011-September 2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Nov; 61(44):899-904. PubMed ID: 23134973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress toward poliomyelitis eradication--Nigeria, January 2013-September 2014.
    Etsano A; Gunnala R; Shuaib F; Damisa E; Mkanda P; Banda R; Korir C; Enemaku O; Corkum M; Usman S; Davis LB; Nganda Gw; Burns CC; Mahoney F; Vertefeuille JF;
    MMWR Morb Mortal Wkly Rep; 2014 Nov; 63(46):1059-63. PubMed ID: 25412063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of polio emergency operations centers: perspectives for future disease control initiatives in Nigeria.
    Braka F; Adamu U; Siddique A; Bolu O; Damisa E; Banda R; Gerald S; Korir C; Usman S; Mohammed A; Aladeshawe S; Tegegne S; Nomhwange T; Waziri E; Nguku P; Erbeto T; Nsubuga P; Shuaib F
    Pan Afr Med J; 2023; 45(Suppl 2):8. PubMed ID: 38370098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles and rubella elimination: learning from polio eradication and moving forward with a diagonal approach.
    Goodson JL; Alexander JP; Linkins RW; Orenstein WA
    Expert Rev Vaccines; 2017 Dec; 16(12):1203-1216. PubMed ID: 29037086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The challenges of insecurity on implementing vaccination campaign and its effect on measles elimination and control efforts: A case study of 2017/18 measles campaign in Borno state, Nigeria.
    Babakura B; Nomhwange T; Jean Baptiste AE; Dede O; Taiwo L; Abba S; Soyemi M; Idowu AM; Terna Richard M; Braka F; Oteri J; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C66-C75. PubMed ID: 33546886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ensuring accountability in implementation of supplementary immunisation activities: A case study of the 2017/2018 measles vaccination campaign in Nigeria.
    Momoh J; Oteri AJ; Mogekwu F; Onwu N; Dieng B; Bawa S; Braka F; Nsubuga P; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C12-C20. PubMed ID: 33714654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National Stop Transmission of Polio Program support for polio supplemental immunization activities in Nigeria 2012-2016: deployment of management support team.
    Edukugho AA; Waziri NE; Bolu O; Gidado SO; Okeke LA; Uba BV; Idris JM; Michael CA; Adegoke JO; Bammeke P; Adamu US; Nguku PM; Biya O; Ohuanbunwo CJ; Vertefeuille J; Damisa E; Wiesen E
    Pan Afr Med J; 2021; 40(Suppl 1):14. PubMed ID: 36157558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using data to improve outcomes of supplemental immunisation activities: 2017/2018 Nigeria measles vaccination campaign.
    Mogekwu FI; Oteri JA; Nsubuga P; Ezebilo O; Maxwell N; Wiwa O; Braka F; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C38-C45. PubMed ID: 33461831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons learned from the polio eradication initiative in the Democratic Republic of Congo and Ethiopia: analysis of implementation barriers and strategies.
    Deressa W; Kayembe P; Neel AH; Mafuta E; Seme A; Alonge O
    BMC Public Health; 2020 Dec; 20(Suppl 4):1807. PubMed ID: 33339529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. World Health Organization's Innovative Direct Disbursement Mechanism for Payment of Grassroots Immunization Personnel and Operations in Nigeria: 2004-2015.
    Yehualashet YG; Wadda A; Agblewonu KB; Zhema T; Ibrahim AA; Corr A; Linkins J; Mkanda P; Vaz RG; Nsubuga P; Ashogbon D
    J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S108-15. PubMed ID: 26908746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polio elimination in Nigeria: A review.
    Nasir UN; Bandyopadhyay AS; Montagnani F; Akite JE; Mungu EB; Uche IV; Ismaila AM
    Hum Vaccin Immunother; 2016 Mar; 12(3):658-63. PubMed ID: 26383769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress toward poliomyelitis eradication - Nigeria, January 2012-September 2013.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Dec; 62(49):1009-13. PubMed ID: 24336134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.